Back to funds
View filing
Samsara BioCapital, LLC
hedge fundUpdated 27 days agoManaged by Samsara Biocapital, Llc • Latest filing Q2 2026
Portfolio value
$1.2B
Q2 2026
Filings
13
Quarterly 13F history
Top-10 concentration
100.0%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings
Portfolio value history
13F-disclosed portfolio value over 14 quarters
Show data table
| Period | Portfolio value |
|---|---|
| Q1 2023 | $483.8M |
| Q2 2023 | $569.7M |
| Q3 2023 | $326.7M |
| Q4 2023 | $642.8M |
| Q1 2024 | $646.4M |
| Q2 2024 | $477.8M |
| Q3 2024 | $520.3M |
| Q4 2024 | $728.6M |
| Q1 2025 | $560.8M |
| Q2 2025 | $488.9M |
| Q3 2025 | $765.9M |
| Q4 2025 | $969.3M |
| Q1 2026 | $1B |
| Q2 2026 | $1.2B |
Top holdings
24 positions as of Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | S SRRK SCHOLAR ROCK HLDG CORP | $379.4M | 6.90M | 31.16% | — |
| 2 | A ALMS ALUMIS INC | $178.6M | 6.35M | 14.67% | — |
| 3 | M MLYS MINERALYS THERAPEUTICS INC | $158.4M | 5.87M | 13.01% | — |
| 4 | S SEPN SEPTERNA INC | $105.5M | 3.15M | 8.66% | — |
| 5 | ? N/A ALAMAR BIOSCIENCES INC | $67.2M | 2.48M | 5.52% | — |
| 6 | N NGNE NEUROGENE INC | $54M | 1.72M | 4.44% | — |
| 7 | ? N/A KALARIS THERAPEUTICS INC | $52.4M | 12.88M | 4.31% | — |
| 8 | S SGP SPYGLASS PHARMA INC | $47M | 2.11M | 3.86% | — |
| 9 | ? N/A SUTRO BIOPHARMA INC | $35.3M | 1.06M | 2.90% | — |
| 10 | I IVEVF INVENTIVA SA | $23.9M | 6.31M | 1.96% | — |
| 11 | J JBIO JADE BIOSCIENCES INC | $16.4M | 736.2K | 1.34% | — |
| 12 | P PBLS PARABILIS MEDICINES INC | $15.2M | 556.0K | 1.25% | — |
| 13 | V VTVT VTV THERAPEUTICS INC | $11.2M | 298.5K | 0.92% | — |
| 14 | A AQST AQUESTIVE THERAPEUTICS INC | $10.4M | 2.50M | 0.85% | — |
| 15 | N NKTX NKARTA INC | $9.9M | 3.51M | 0.82% | — |
| 16 | ? N/A ARTIVA BIOTHERAPEUTICS INC | $9.3M | 954.9K | 0.76% | — |
| 17 | R RANI RANI THERAPEUTICS HLDGS INC | $7.9M | 10.37M | 0.65% | — |
| 18 | A AGMB AGOMAB THERAPEUTICS NV | $7.8M | 600.0K | 0.64% | — |
| 19 | A AAVXF ABIVAX SA | $7.3M | 55.1K | 0.60% | — |
| 20 | ? N/A X4 PHARMACEUTICALS INC | $6.5M | 1.40M | 0.54% | — |